{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:56Z","timestamp":1793946536745,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.metabol.2026.156591","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:59:08Z","timestamp":1773421148000},"page":"156591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mapping circulating microRNA signatures in type 1 diabetic microvascular disease: A systematic review and Bayesian multilevel meta-analysis with bioinformatic integration of molecular dysregulation"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6643-5603","authenticated-orcid":false,"given":"Yousef","family":"Khadivi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9968-9758","authenticated-orcid":false,"given":"Pardis","family":"Tavallaeinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6032-5523","authenticated-orcid":false,"given":"Mahin","family":"Hashemipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-5981","authenticated-orcid":false,"given":"Arvin","family":"Khachikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-781X","authenticated-orcid":false,"given":"Silva","family":"Hovsepian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156591_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00331","article-title":"Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy","volume":"8","author":"Penaforte-Saboia","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-019-0961-7","article-title":"Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study","volume":"18","author":"Garofolo","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.metabol.2026.156591_bb0015","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4161\/rna.20162","article-title":"MicroRNAs in diabetes and diabetes-associated complications","volume":"9","author":"Lorenzen","year":"2012","journal-title":"RNA Biol"},{"key":"10.1016\/j.metabol.2026.156591_bb0020","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.metabol.2026.156591_bb0025","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db11-0082","article-title":"Diabetes complications: the microRNA perspective","volume":"60","author":"Kantharidis","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156591_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6890501","article-title":"MicroRNA and microvascular complications of diabetes","volume":"2018","author":"Barutta","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"21","key":"10.1016\/j.metabol.2026.156591_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112843","article-title":"miRNAs as biomarkers in diabetes: moving towards precision medicine","volume":"23","author":"Angelescu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.metabol.2026.156591_bb0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40620-018-0511-5","article-title":"Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies","volume":"31","author":"Gholaminejad","year":"2018","journal-title":"J Nephrol"},{"key":"10.1016\/j.metabol.2026.156591_bb0045","article-title":"MicroRNAs in the progress of diabetic nephropathy: a systematic review and meta-analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"10.1016\/j.metabol.2026.156591_bb0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/dna.2019.4942","article-title":"microRNA expression profiling based on microarray approach in human diabetic retinopathy: a systematic review and meta-analysis","volume":"39","author":"Zhou","year":"2020","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.metabol.2026.156591_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.929924","article-title":"Circulating microRNAs as potential diagnostic biomarkers for diabetic retinopathy: a meta-analysis","volume":"13","author":"Ma","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0060","first-page":"86","article-title":"Discovering diabetes complications-related microRNAs: meta-analyses and pathway modeling approach","volume":"18","author":"Yin","year":"2025","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.metabol.2026.156591_bb0065","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.metabol.2026.156591_bb0070","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.metabol.2026.156591_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"issue":"17","key":"10.1016\/j.metabol.2026.156591_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku631","article-title":"The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations","volume":"42","author":"Ru","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2026.156591_bb0090","series-title":"multiMiR: integration of multiple microRNA-target databases with their disease and drug associations","author":"MM","year":"2024"},{"issue":"2","key":"10.1016\/j.metabol.2026.156591_bb0095","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol Biosyst"},{"issue":"5","key":"10.1016\/j.metabol.2026.156591_bb0100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodology"},{"key":"10.1016\/j.metabol.2026.156591_bb0110","series-title":"Statistical methods for meta-analysis","volume":"1985","author":"Hedges","year":"1985"},{"key":"10.1016\/j.metabol.2026.156591_bb0115","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"issue":"17","key":"10.1016\/j.metabol.2026.156591_bb0120","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/sim.1482","article-title":"Improved tests for a random effects meta-regression with a single covariate","volume":"22","author":"Knapp","year":"2003","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"7414","key":"10.1016\/j.metabol.2026.156591_bb0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jrsm.5","article-title":"Robust variance estimation in meta-regression with dependent effect size estimates","volume":"1","author":"Hedges","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.metabol.2026.156591_bb0140","series-title":"Introduction to robust estimation and hypothesis testing","author":"Wilcox","year":"2011"},{"issue":"7109","key":"10.1016\/j.metabol.2026.156591_bb0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2026.156591_bb0150","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","year":"2024"},{"key":"10.1016\/j.metabol.2026.156591_bb0155","series-title":"Bayesian data analysis","author":"Gelman","year":"2013"},{"issue":"5","key":"10.1016\/j.metabol.2026.156591_bb0160","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11222-016-9696-4","article-title":"Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC","volume":"27","author":"Vehtari","year":"2017","journal-title":"Stat Comput"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0165","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad468","article-title":"Serum microRNA-191-5p levels in vascular complications of type 1 diabetes: the EURODIAB prospective complications study","volume":"109","author":"Bellini","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metabol.2026.156591_bb0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1681\/ASN.2011010055","article-title":"Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis","volume":"23","author":"Wang","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2026.156591_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DMSO.S441082","article-title":"MicroRNA-204-5p ameliorates renal injury via regulating Keap1\/Nrf2 pathway in diabetic kidney disease","volume":"17","author":"Dong","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.metabol.2026.156591_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/DMSO.S346097","article-title":"Decreased levels of miR-126 and miR-132 in plasma and vitreous humor of non-proliferative diabetic retinopathy among subjects with type-2 diabetes mellitus","volume":"15","author":"Pramanik","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.metabol.2026.156591_bb0185","article-title":"The Wnt signaling pathway in diabetic nephropathy","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.metabol.2026.156591_bb0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.visres.2017.02.007","article-title":"Canonical Wnt signaling in diabetic retinopathy","volume":"139","author":"Chen","year":"2017","journal-title":"Vision Res"},{"issue":"6","key":"10.1016\/j.metabol.2026.156591_bb0195","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bbamcr.2008.10.005","article-title":"Inositol trisphosphate and calcium signalling mechanisms","volume":"1793","author":"Berridge","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00592-018-1216-x","article-title":"Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses","volume":"56","author":"Assmann","year":"2019","journal-title":"Acta Diabetol"},{"issue":"11","key":"10.1016\/j.metabol.2026.156591_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073798","article-title":"Urinary exosomal microRNAs in incipient diabetic nephropathy","volume":"8","author":"Barutta","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.metabol.2026.156591_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00592-016-0915-4","article-title":"MicroRNA-126 and micro-\/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study","volume":"54","author":"Barutta","year":"2017","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156591_bb0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00410281","article-title":"Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study","volume":"38","author":"Aldington","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156591_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109987","article-title":"Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 diabetes: the EURODIAB prospective complications study","volume":"190","author":"Barutta","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.metabol.2026.156591_bb0225","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1167\/iovs.15-16498","article-title":"Expression of angiogenic microRNAs in endothelial progenitor cells from type 1 diabetic patients with and without diabetic retinopathy","volume":"56","author":"Garcia de la Torre","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.metabol.2026.156591_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00563","article-title":"MiR-30e-5p and MiR-15a-5p expressions in plasma and urine of type 1 diabetic patients with diabetic kidney disease","volume":"10","author":"Dieter","year":"2019","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.metabol.2026.156591_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/ijn.IJN_80_19","article-title":"MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetes","volume":"30","author":"Fouad","year":"2020","journal-title":"Indian J Nephrol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:56:44Z","timestamp":1793944604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"alternative-id":["S0026049526001010"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156591","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping circulating microRNA signatures in type 1 diabetic microvascular disease: A systematic review and Bayesian multilevel meta-analysis with bioinformatic integration of molecular dysregulation","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156591"}}